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Background: A life threatening illness such as breast cancer can lead to a secondary diagnosis of PTSD
(post traumatic stress disorder) with intrusive thoughts and avoidance as major symptoms. In a former study by the
research group, 80% of the patients with breast cancer reported a high level of stress symptoms close to the
diagnosis, such as intrusive thoughts and avoidance behavior. These symptoms remained high throughout the
study. The present paper presents the design of a randomized study evaluating the effectiveness and
cost-effectiveness of a stress management intervention using a stepped-care design.
Method: Female patients over the age of 18, with a recent diagnosis of breast cancer and scheduled for adjuvant
treatment in the form of chemotherapy, radiation therapy and/or hormonal therapy are eligible and will
consecutively be included in the study. The study is a prospective longitudinal intervention study with a
stepped-care approach, where patients will be randomised to one of two interventions in the final stage of
treatment. The first step is a low intensity stress-management intervention that is given to all patients. Patients who
do not respond to this level are thereafter given more intensive treatment at later steps in the program and will be
randomized to more intensive stress-management intervention in a group setting or individually. The primary
out-come is subjective distress (intrusion and avoidance) assessed by the Impact of Event Scale (IES). According to
the power-analyses, 300 patients are planned to be included in the study and will be followed for one year. Other
outcomes are anxiety, depression, quality of life, fatigue, stress in daily living and utilization of hospital services. This
will be assessed with well-known psychometric tested questionnaires. Also, the cost-effectiveness of the
intervention given in group or individually will be evaluated.
Discussion: This randomized clinical trial will provide additional empirical evidence regarding the effectiveness of a
stress-management program given in group or individually during adjuvant therapy in terms of decreased stress,
minimizing fatigue, and maintaining or enhancing patients’ quality of life and psychological well-being.
Trial registration: ClinicalTrials.gov Identifier: NCT01555645
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A life threatening illness such as breast cancer can lead to
a secondary diagnosis of PTSD (post traumatic stress dis-
order) [1]. The reported frequency of PTSD for breast can-
cer patients varies between 2–22%, depending on methods
of measurement. At present it is therefore difficult to draw
any conclusions about the actual prevalence of PTSD. In-
trusive thoughts, avoidance behavior and worry are all
common symptoms. Nordin and Glimelius [2] reported
that clinical levels of worry or depression in combination
with intrusive thoughts in individuals with breast cancer
make it possible to identify women who will need psycho-
logical support at a later stage of treatment. In a study [3]
it was found that measures of avoidance behavior could
predict the effects of treatment on an individual’s quality
of life. Extensive avoidance behavior at the start of treat-
ment is correlated with deterioration in physical and social
functioning as well as impaired general health. Half of the
women diagnosed with breast cancer in Sweden are under
the age of 65 and at least theoretically gainfully employed
[4]. To juggle the demands of work and a family, especially
when there are children living at home, is a demanding
task [5]. To be diagnosed with breast cancer on top of
these demands can be the straw that breaks the camel’s
back. At present there is very little research that has exam-
ined this combination of stress factors in women diag-
nosed with breast cancer.
In an international perspective there is a fair amount of
evidence which indicates that methods which are based on
cognitive behavior therapy can improve health-related
quality of life (HRQoL), reduce psychosocial stress and in-
crease perceived Personal control of treatment side-effects
and disease symptoms for cancer patients [6,7]. According
to SBU (The Swedish Council on Technology Assessment
in Health Care) providing cognitive behavior therapy 1–3
months after a traumatic event reduces the occurrence of
PTSD in states of intensive stress [8]. At present there is a
lack of solid research findings for comparisons of cost-
effectiveness and outcome [8].
The research group “Support project” has studied the
effect of individual counselling conducted by a specially
trained nurse [9]. This intervention was compared to the
results of therapy conducted by a psychologist and to a
group that received treatment as usual. The project started
in 1997 with special training for nurses [10]. The project
continued during for the next 5 years and data collection
was concluded in January 2002. Patients in this study had
been diagnosed with breast cancer and were offered adju-
vant treatment. A total of 179 patients were consecutively
included. The results showed that both active treatments
had a positive effect, measured in terms of increased
HRQoL and decreased symptoms of stress (e.g. intrusive
thoughts) in comparison to the control group who
received treatment as usual [9]. More patients in thecontrol group took advantage of the psychosocial support
that was available for all patients in standard care as com-
pared to both intervention groups. The level of satisfaction
was generally high in both intervention groups [11]. How-
ever patients in the nurse-counselor groups reported that
greater satisfaction with interventions for worry, informa-
tion about their illness, prognosis, tests, treatment as well
as general contact with health care facilities than patients
in the psychologist groups. Utilization of health care and
number of days on sick leave can be attributed to the adju-
vant treatment [12]. Both the intervention groups had
lower total costs for medical care than the control group
who required more days for in-patient care. The conclu-
sions that can be drawn from this study are that the psy-
chosocial interventions were useful for breast cancer
patients, that they were relatively inexpensive and that
interventions offered by nurses were as effective as those
given by psychologists. The results of the “Support Project”
described above generated additional questions. Most
patients reported relatively high levels of HRQoL as well as
relatively low levels of symptoms and side-effects of their
illness and treatment. Despite these findings 75% of the
patients reported that they had problems for which the psy-
chosocial interventions provided help. A more detailed ana-
lysis of the data showed that 80% of the patients in the
study reported a high level of stress symptoms initially,
such as intrusive thoughts and avoidance behavior. These
symptoms remained high throughout the study. Other
symptoms such as worry and depression were also reported
at high levels initially but these symptoms had decreased to
normal levels after 3 months. This indicates that here is a
need for closer examination of other factors for breast can-
cer patients, such as stress-related symptoms and behavior,
predictors for stress, effects on role and social functions as
well as utilization of heath care, sick leave and return to
work settings. In addition there is a need to study how psy-
chosocial interventions with a focus on stress management
can influence the above-mentioned factors.
This paper presents the design of a randomized multi-
centre trial to evaluate the effectiveness and cost-
effectiveness of a stress management intervention using
a stepped- care approach. The first step is a low intensity
intervention that is given to all patients. Patients who do
not respond to this level are thereafter given more inten-
sive treatment at step 2 in the program. They will in step
2 be randomised to more intensive stress-management
intervention in a group setting or individual. The
hypothesis is that half of the individuals assigned to a
low intensity intervention will be significantly improved
after treatment. For individuals who continue to have
symptoms after low intensity treatment it is hypothe-
sized that continued treatment in a group setting with
high intensity interventions will be more cost-effective.
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Figure 1 Study design.
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duction in socio-economic costs.
Methods
Patients
Female patients over the age of 18, with a recent diagno-
sis of breast cancer and scheduled for adjuvant treatment
in the form of chemotherapy, radiation therapy and/or
hormonal therapy are eligible for this study and will
consecutively be included in the project. Patients will be
recruited from three hospitals in the central part of
Sweden (Uppsala, Gävle and Falun). Criteria for exclu-
sion are an ongoing psychiatric condition or language
deficiencies in Swedish. According to the power calcula-
tions, a total sample of 300 patients is necessary.
Design
The study is a prospective longitudinal intervention study
with a stepped-care approach [13], where patients will be
randomised to one of two interventions in the final stage
of treatment. One of the key concepts in the stepped-care
model is that the needs of the individual are matched to
the appropriate level of care [13]. The first step is a low
intensity intervention that is given to all patients. Patients
who do not respond to this level are thereafter given more
intensive treatment at later steps in the program. Since
methods from CBT (cognitive behavior therapy) have
already been shown not only to reduce the risk for PTSD
[8] but also to have a positive effect on quality of life and
psychological well being for patients with breast cancer
[9,14], there is no control group in the study. All patients
(n= 300) will receive the first level of the intervention pro-
gram. All patients (estimated to n= 150) who continue to
report stress symptoms after the first step of the interven-
tion program will be given the chance to participate in the
second step of the program. The second step includes ran-
domisation to one of two treatments: a stress management
group or individual stress management (See Figure 1).
With this design it will be possible to study the prevalence
of stress related symptoms as well as to study which fac-
tors predict which patients will be Clinically Significant
Improved (CSI) with a basic level of education about stress
management. In addition the study will help to identify
those patients who need additional help and to compare
the effects of individual and group interventions.
Intervention
All patients start at the first step of the intervention pro-
gram and receive detailed information about different
stress symptoms and different ways to deal with them.
Patients will be given the opportunity to ask questions
and will receive written material to be read at home. All
patients are evaluated at the end of the intervention
(Table 1) to see if they are clinically significant improved(CSI). CSI is defined as a decrease in stress related symp-
toms as measured by Impact of Event Scale (IES) and/or
the Hospital and Depression Scale (HADS) from clinical
levels to normal results. Patients who are evaluated as
CSI as well as patients who did not report clinical levels
on IES or HADS at the start of the intervention leave
the program but are followed up during the coming year
(Table 1). The remaining patients will be asked if they
wish to continue in the program to the next step. Those
patients who wish to continue will be randomised to
group (Step 2a) or individual stress management (Step
2b). Within a week after randomisation patients will be
contacted by telephone to receive information about
which group they are assigned to and practical details
about the start of the intervention.
Table 1 Summary of interventions and measures used at repeated points in time
Time of assessment
Questionnaire Inclusion InterventionStep 1 3 months
after inclusion






n 300 300 300 150 150 300
IES [15] X X X X
HADS [16] X X X X
EORTC QLQ C-30 [17] X X X X
EORTC QLQ BR-23 [18] X X X X
EQ-5D [19] X X X X
MFI [20,21] X X X X
Stress in daily living [22] X X X X
Self-reported sick leave and
use of other professional services
X X X X




PGPQ [23] (n = 150) X X X
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Step 2a
Stress management, group format. Participants (6–8
patients/group) will meet for 2 hours every week for a
total of 20 hours. In the intervals between the group
meetings patients will be asked to do homework. This
homework can entail practicing problem-solving techni-
ques, keeping a diary, practicing relaxation or participat-
ing in physical activities. Each group meeting has a
specific subject, derived from the 6 components in the
intervention [24]. These components concern 1) basic
knowledge about cancer, treatment, healthy living and
stress reactions, 2) self-awareness with the help of a diary
for thoughts, feelings and behavior, as well as group dis-
cussions of specific cases 3) instruction in various techni-
ques about how to express negative feelings, how to
communicate with others more effectively how to change
behaviors related to stress, anger, worry and depression
4) training these techniques in real-life situations outside
the group, 5) cognitive restructuring with the help of
diaries, techniques and group dynamics and 6) spiritual-
ity, in a broad sense, with group discussions of quality of
life, values, self-confidence and optimism. Written mate-
rials, case studies and video presentations will be used.
Step 2b Individual intervention
The methods and techniques will be the same as those
used in the group intervention. The first session will be
used for a detailed assessment of the individual’s psycho-
social problems, as used in earlier studies [9,11]. The ses-
sions will last 45–60 minutes. The number of sessions will
depend on the individual patient’s problems and the jointassessment made by the patient and nurse together. The
total number of sessions will be at least 4, with a maximum
of 8. The contents of the sessions are Session 1: Assess-
ment, Session 2: Analysis of diary (self-registration) and
suggestions for problem management, Session 3: Evaluation
of problem management skills Session 4: Follow-up and
conclusion of the intervention. When necessary Sessions
5–8 will address specific obstacles and continued practice.
Implementation
Patients will receive written information about the pro-
ject when they receive notice for a doctor’s appointment
to discuss adjuvant treatment for breast cancer. They will
be asked if they wish to participate in the project for
stress management by their doctor or by a member of
the project group after the appointment. If they answer
“yes” they will then receive the first set of questionnaires.
Their answers constitute the baseline measures as well
as a prevalence screening for stress symptoms. When the
questionnaires are completed the patient will receive a
written invitation to Step 1 of the intervention program,
i.e. to a lecture on stress management. The intervention
program will take place in Falun, Gävle or Uppsala, and
be conducted by specially trained nurses who will receive
continual supervision. The nurses who conduct the
intervention program will be trained in general stress
management, psychosocial oncology as well as assess-
ment and treatment of psychosocial problems.
Data collection
Data will be collected by use of well-known questionnaires.
An outline of the assessment points and questionnaires are
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study, they were mailed the baseline questionnaires, which
included a signed consent to participate and a prepaid enve-
lope. Later measurements will be sent out to the patients’
homes, together with a stamped, pre-addressed envelope.
Patients who have not returned the completed question-
naires after 14 days will be contacted by telephone by a
member of the project staff to insure as high a response rate
as possible. Information about the patients’ demographic
and medical background will be obtained from their med-
ical records. Utilization of hospital services will be collected
from the hospitals’ computer systems. Information about
utilization of other professional care facilities will be col-
lected from patients’ self-reports. Sick-leave information will
also be collected by self-report. The nurse-counsellor will
record attendance at individual and group sessions.Data analysis
SPSSW ANOVA will be used to analyze differences
between groups and for repeated measures over time for
the continuous variables while nominal (categorical)
variables will be tested with chi square (exact). Although
not all the criteria for normal distribution are met by
this selection the parametric tests are robust enough to
be used. Patients’ levels of stress related symptoms will
be categorized according to recognized cut-off points
(See references in Table 1). A hierarchical linear regres-
sion analysis will be used to examine which variables
predict stress symptoms and utilization of health care
services as well as sick leave and return to work. Power
calculations have been done for IES based on data from
Support Project. On the basis of these conditions
(power = 0.8, p = .05 and effect size = 0.59) at least 64
patients must be included in each group (i.e. a total of
128) patients) to detect a significant difference on IES.Ethical considerations
The project has been approved the Regional Ethical Re-
view Board in Uppsala 20090327, Diary number 2008/
382. A written informed consent for participation in the
study was obtained from participants. The interventions
in the project will be provided by specially trained staff
and supervised continuously so that any potentially
harmful interventions can be detected early in treatment
and corrected immediately. Filling in numerous ques-
tionnaires can be demanding. The questionnaires used
in this study have been chosen with care, both in terms
of length and number. However, if the number or length
of questionnaires were to be further reduced it could
make it difficult to reach any conclusions, which would
reduce the value of this study for patients and grant-
givers alike.Discussion
The interventions that are planned for in this project are
directed towards symptoms that can make or break the
course of illness for an individual patient. Hopefully the
project will show that a stepped-care approach can help
and support individual patients at the right level of care.
All patients will receive stress management training. Those
who require more help will receive additional treatment
for their symptoms in the form of individual or group
counselling. Health care and society may gain substantially
from the planned intervention program, both in the form
of individualized psychosocial support and reduced
utilization of health care, preserved work capacity or a
quicker return to work. The more intensive support will
only be offered to those patients who show a clear need.
For research purposes it is also important to increase what
is known about stressors that are specific to women diag-
nosed with breast cancer and to develop interventions that
are directed at these symptoms. This study will be con-
ducted in three different counties in central Sweden which
contributes to increased generalization and dissemination
of the results of the study. This can lead to implementation
of similar evidenced-based psychosocial care for cancer
patients within a large geographical area.
Limitations of the study should be noted as well. The
lack of a true control-group in step-2 can result in difficul-
ties to interpret the effects of the stress-intervention. If
there is a positive result, we cannot be absolutely sure that
this effect would not be present in an untreated group.
However, we consider not to have a untreated control
since methods from CBT (cognitive behavior therapy) have
already been shown not only to reduce the risk for PTSD
[8] but also to have a positive effect on quality of life and
psychological well being for patients with breast cancer
[9,14]. It would not be ethical to withdraw patients in need
from a treatment that has been found effective.
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